NAVIDEA BIOPHARMACEUTICALS, INC. Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Navidea Biopharmaceuticals, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q3 2023.
  • Navidea Biopharmaceuticals, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2023 was $11.8K, a 62.9% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $11.8K -$20K -62.9% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $11.8K -$215K -94.8% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $11.8K -$215K -94.8% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $11.8K -$215K -94.8% Dec 31, 2022 10-Q 2023-11-14
Q3 2022 $31.8K -$195K -86% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $227K $0 0% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $227K $0 0% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $227K $0 0% Dec 31, 2021 10-K 2023-03-27
Q3 2021 $227K $0 0% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $227K $0 0% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $227K $0 0% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $227K -$311K -57.8% Dec 31, 2020 10-K 2022-03-28
Q3 2020 $227K -$601K -72.6% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 $227K -$601K -72.6% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $227K -$608K -72.8% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $538K -$297K -35.6% Dec 31, 2019 10-K 2021-03-26
Q3 2019 $828K -$539K -39.4% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $828K -$609K -42.4% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $835K -$603K -41.9% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $835K -$610K -42.2% Dec 31, 2018 10-K 2020-03-18
Q3 2018 $1.37M +$1.15M +535% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $1.44M +$1.22M +568% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 $1.44M +$1.23M +586% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $1.44M +$1.24M +612% Dec 31, 2017 10-K 2019-03-15
Q3 2017 $215K +$11.7K +5.72% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $215K +$207K +2507% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $210K -$72K -25.6% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $203K -$70.7K -25.8% Dec 31, 2016 10-K 2018-03-15
Q3 2016 $204K -$69.9K -25.5% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $8.26K -$265K -97% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 $282K -$98.3K -25.9% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 $274K -$25.5K -8.52% Dec 31, 2015 8-K 2017-12-15
Q3 2015 $274K -$124K -31.3% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $274K +$140K +105% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 $380K +$238K +168% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $299K -$424K -58.6% Dec 31, 2014 10-K 2016-03-23
Q3 2014 $398K -$418K -51.3% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $134K -$776K -85.3% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 $142K -$122K -46.3% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 $723K +$395K +120% Dec 31, 2013 10-K 2015-03-16
Q3 2013 $816K +$415K +104% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $909K +$428K +89.1% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 $264K -$298K -53.1% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 $328K -$271K -45.2% Dec 31, 2012 10-K 2014-03-14
Q3 2012 $401K +$394K +5303% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 $481K +$474K +6381% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 $562K Mar 31, 2012 10-Q 2012-05-10
Q4 2011 $599K +$591K +7968% Dec 31, 2011 10-K/A 2013-03-21
Q3 2011 $7.42K Sep 30, 2011 10-Q 2011-11-09
Q2 2011 $7.42K Jun 30, 2011 10-Q 2011-08-08
Q4 2010 $7.42K Dec 31, 2010 10-K 2012-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.